1. Kanis JA. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporosis Int. 1994. 4:368–381.
Article
2. Chrischilles E, Shireman T, Wallace R. Costs and health effects of osteoporotic fracture. Bone. 1994. 15:377–386.
3. Schwartz AV, Kelsey JL, Maggi S, Tuttleman M, Ho SG, Jonsson PV, Poor G, Sisson de Castro JA, Xu L, Matkin CC, Nelson LM, Heyse SP. International variation in the incidence of hip fractures: cross-national project on osteoporosis for the World Health Organization Program for Research on Aging. Osteoporosis Int. 1999. 9:242–253.
Article
4. Price PA. Vitamin K nutrition and postmenopausal osteoporosis. J Clin Invest. 1993. 91:1268.
Article
5. Price PA, Parthemore JG, Deftos LJ, Nishimoto SK. New biochemical marker for bone metabolism: measurement by radioimmunoassay of bone gla-protein in the plasma of normal subjects and proteins with bone disease. J Clin Invest. 1980. 66:878–883.
6. Miura M. Biochemical markers of bone turnover New aspect An automated assay for measuring bone turnover markers. Clin Calcium. 2009. 19:1160–1169.
7. Furie B, Bouchard BA, Furie BC. Vitamin K dependent biosynthesis of gamma-carboxyglutamic acid. Blood. 1999. 93:1798–1808.
8. Vermeer C, Jie KS, Knapen MH. Role of vitamin K in the bone metabolism. Annu Rev Nutr. 1995. 15:1–22.
9. Haffa A, Krueger D, Bruner J, Engelke J, Gundberg C, Akhter M, Binkley N. Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats. J Bone Miner Res. 2000. 15:872–878.
Article
10. Price PA, Williamson MK, Lothringer JW. Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone. J Biol Chem. 1981. 256:12760–12766.
Article
11. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993. 91:1769–1774.
Article
12. Bügel S. Litwack G, editor. Vitamin K and bone health in adult humans. Vitamins and Hormones. 2008. vol 78:1st ed. USA: Academic Press (Elsevier);393–416.
Article
13. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med. 1992. 327:1637–1642.
Article
14. Reid DM, Macdonald HM. Nutrition and bone: Is there more to it than just calcium and vitamin D? QJM. 2001. 94:53–56.
Article
15. Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-carboxylation. Blood. 1990. 75:1753–1762.
Article
16. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW. A high phylloquinone intake is required to achieve maximal osteocalcin γ-carboxylation. Am J Clin Nutr. 2002. 76:1055–1060.
Article
17. Booth SL, Lichtenstein AH, O'Brien-Morse M, McKeown NM, Wood RJ, Saltzman E, Gundberg CM. Effects of a hydrogenated form of vitamin K on bone formation and resorption. Am J Clin Nutr. 2001. 74:783–790.
Article
18. Booth SL, Broe KE, Peterson JW, Cheng DM, Dawson-Hughes B, Gundberg CM, Cupples LA, Wilson PW, Kiel DP. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab. 2004. 89:4904–4909.
Article
19. Hodges SJ, Akesson K, Vergnaud P, Obrant K, Delmas PD. Circulating levels of Vitamin K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res. 1993. 8:1241–1245.
20. Weber P. The role of vitamins in the prevention of osteoporosis-a brief status report. Int J Vitam Nutr Res. 1999. 69:194–197.
21. Nimptsch K, Hailer S, Rohrmann S, Gedrich K, Wolfram G, Linseisen J. Determinants and correlates of serum undercarboxylated osteocalcin. Ann Nutr Metab. 2007. 51:563–570.
Article
22. Sokoll LJ, Sadowski JA. Comparison of biochemical indexes for assessing vitamin K nutritional status in a healthy adult population. Am J Clin Nutr. 1996. 63:566–573.
Article
23. Bunyaratavej N, Soontrapa S, Rojanasthin S, Kitimanon N, Lektrakul S. Level of undercarboxylated osteocalcin in reproductive Thai females. J Med Assoc Thai. 2005. 1:Suppl 5. S37–S39.
24. Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women. Maturitas. 2007. 56:288–296.
Article
25. Epstein S, Poser J, McClintock R, Johnston CC Jr, Bryce G, Hui S. Differences in serum bone GLA protein with age and sex. Lancet. 1984. 1:307–310.
Article
26. Liu G, Peacock M. Age-related changes in serum undercarboxylated osteocalcin and its relationship with bone density, bone quality, and hip fracture. Calcified Tissue Int. 1998. 62:286–289.
27. Yasui T, Uemura H, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M. Undercarboxylated osteocalcin concentration in postmenopausal women receiving hormone therapy daily and on alternate days. Menopause. 2006. 13:314–322.
Article
28. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002. 1570:27–32.
Article
29. Kim SY, Oh HJ, Chang SY. Comparison of bone mineral density and lipid profiles in pre and postmenopausal women. J Korean Acad Fam Med. 1997. 18:910–917.
30. Knapen MH, Nieuwenhuijzen-Kruseman AC, Wouters RS, Vermeer C. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int. 1998. 63:375–379.
Article